CVS Health's stock rallied more than 9% after the company raised its full-year outlook, bolstered by better-than-expected first-quarter earnings. The firm reported revenues of $100.4 billion and adjusted earnings per share of $2.57, surpassing analyst expectations. With an increased full-year adjusted EPS forecast of $7.30 to $7.50, CVS is reflecting strong growth potential, further reassuring investors as its shares have appreciated approximately 30% over the past year.
“CVS Health · closed up · value · +7%”
“CVS Health · is up · percentage · +7%”
“CVS Health · is up · percentage · +9%”
“CVS Health (CVS) · raised · its full-year outlook · following better-than-expected first quarter earnings”
“CVS Health (CVS) · recorded · revenue · $100.4B”
“CVS Health (CVS) · achieved · adjusted EPS · $2.57”
“CVS Health · jumped · over 7% · after raising its full-year outlook”
“CVS Health · increased adjusted earnings per share outlook · $7.30-$7.50 · from $7.00-$7.20”
“CVS Health · is up · more than · +9%”
“CVS Health · raised · full-year adjusted EPS forecast · to $7.30 to $7.50”
“CVS Health · is up · value · +7%”
“CVS Health · is up · more than +9%”
